At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Posted on: 23 September, 2025
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert tea..... Read more
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 22 September, 2025
Bowel cancer is the third most common type of cancer in Australia and treating it is both costl..... Read more
Category: Research Excellence
Posted on: 24 June, 2025
A fascinating and informative podcast has been launched showcasing groundbreaking research, in..... Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence